Donald Engelman
Donald M. Engelman (born 1941) is Higgins Professor of Biochemistry at Yale University. He is a fellow of the American Academy of Arts and Sciences,[1] a fellow of the National Institutes of Health,[2] and has been a Guggenheim fellow.[3] He is a director of the Stryker Corporation.[4] He is involved in the creation of new cancer drugs and treatments.[5] For example, Engelman is involved in research to use peptides to aid in destroying tumors.[6]
Administration, Advising, and Consulting
Engelman has served as Director of Biological Sciences at Yale, an advisor to the Brookhaven National Laboratory, and a consultant to the Los Alamos National Laboratory.[7] He also served as Acting Dean of Yale College in 1991.[8]
Education
Engelman is a graduate (and trustee[9]) of Reed College and Yale University.[10]
Engelman Lab
Engelman directs the Engelman Laboratory at Yale.[11]
Patents
Engelman holds six United States patents for his discoveries.[12]
References
- ↑ http://www.reed.edu/ir/aaa&swawards.html
- ↑ http://www.nndb.com/people/189/000172670/
- ↑ "All Fellows - John Simon Guggenheim Memorial Foundation". Gf.org. Retrieved 2011-07-06.
- ↑ "Donald M. Engelman Profile - Forbes.com". People.forbes.com. Retrieved 2011-07-06.
- ↑ http://www.redorbit.com/news/health/1776007/uri_research_couples_method_targets_cancerous_tumors/
- ↑ http://www.healthimaging.com/index.php?option=com_articles&article=19339
- ↑ http://web.reed.edu/reed_magazine/aug2004/columns/NoC/engleman.html
- ↑ "A Yale College Dean Is Named". The New York Times. 1991-10-15.
- ↑ http://investing.businessweek.com/research/stocks/people/person.asp?personId=633961&ticker=SYK:US&previousCapId=3768366&previousTitle=Amherst%20College
- ↑ "The Engelman Lab - Donald M. Engelman". Yale.edu. Retrieved 2011-07-06.
- ↑ "The Engelman Lab". Yale.edu. Retrieved 2011-07-06.
- ↑ http://www.patentmaps.com/inventor/Donald_M_Engelman_1.html